Phase 2 Data: The Evidence That Set Expectations The Phase 2 trial of retatrutide in adults with obesity, published in The New England Journal of Medicine in 2023, enrolled 338 participants across multiple dose cohorts and a placebo arm over 48 weeks [1]
So just I want to get that out of the way right now because you may have seen that kind of misinformation online already
They may be beneficial short-term
However, rapid weight loss itself can sometimes temporarily shift how your body processes thyroid medications, which is why dose monitoring remains important
Timing your medication strategically Some users find that timing their semaglutide injection or tirzepatide dose to coincide with a specific day of the week helps them manage side effects better
GHK-Cu (Copper Peptide) is commonly used in wellness and anti-aging programs for skin, hair, and recovery support